Trial Details
Not RecruitingBasic Information
| Clinical ID | c5108 |
|---|---|
| Identifier | EUCTR2013-000891-13-DE |
| Trial Title | A randomised, double-blind, placebo-controlled multi-centre study to investigate the effectiveness and safety of STW5-II as add-on treatment for induction of remission in patients with mild to moderate ulcerative colitits |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Ulcerative colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: Iberogast NProduct Name: Iberogast NProduct Code: STW5-IIPharmaceutical Form: Oral drops, liquidINN or Proposed INN: Bitterschleifenblume-ganzpflanze 1,5ml/10mlOther descriptive name: BITTER CANDYTUFT FRESH PLANT EXTRAC |
Participant Information
| Sponsor | Steigerwald Arzneimittelwerk GmbH |
|---|---|
| City | NULL |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |